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Alterations of skeletal muscle microcirculation
detected by blood oxygenation level-dependent
MRI in a patient with granulomatosis with
polyangiitis
SIR, Granulomatosis with polyangiitis (GPA) is a small
vessel vasculitis that is associated with cardiovascular
disease, which mainly determines the prognosis of GPA
patients [1, 2]. Contradictory evidence has been published
regarding accelerated atherosclerosis in GPA, which
might cause cardiovascular morbidity [3, 4]. Blood oxy-
genation level-dependent (BOLD) MRI of skeletal muscle
has become a valuable tool for the assessment of vascu-
lar pathologies such as atherosclerosis, diabetes mellitus
and chronic compartment syndrome [57]. T2*-weighted
MR signal of gradient-echo echo-planar imaging (EPI)
sequences is sensitive to changes of oxyhaemoglobin
concentration in small pre- and post-capillary vessels [8].
Here we present a case of a 73-year-old female GPA pa-
tient who was treated in our rheumatology clinic owing to
severe myalgias. She had a 7-year history of GPA with naso-
pharyngeal symptoms, haemoptysis, arthritis, dysesthe-
sias and renal involvement. During her actual admission,
laboratory tests revealed leucopenia of 2.6/nl (reference
range 3.510.0/nl), lymphopenia of 0.21/nl (0.93.3/nl), hae-
matocrit 0.38 l/l (0.360.46 l/l), CRP 0.4 mg/l (<10 mg/l),
BSG 10 mm/h (028 mm/h), ANCA 1 : 20 (<1 : 20),
anti-MPO <2.5 U/ml (<5 U/ml) and anti-PR3 6 U/ml (<5
U/ml). Her blood pressure was 130/70 mmHg. She had no
history of hypertension, diabetes mellitus or hyperlipida-
emia. Her peripheral pulse status was normal and she
never suffered from claudication. Recent maintenance im-
munosuppressive medication consisted of 150 mg
azathioprine and 10 mg prednisone daily. MRI measure-
ments were indicated owing to severe myalgias of both
legs and performed on a 3.0-T scanner (Verio, Siemens
Medical Solutions, Erlangen, Germany). Informed consent
was obtained, and the study was approved by the local
ethics committee (Ethikkommission beider Basel). A
T2-weighted sequence revealed no signs of local inflamma-
tory activity of the calves. For BOLD imaging, a healthy
female volunteer controlled for age, BMI and physical ac-
tivity served as control after providing consent. A multi-echo
gradient-echo EPI sequence with fat suppression was used
with a cuff compression paradigm as previously described
[5, 9, 10]. Briefly, BOLD imaging was performed during the
last minute of a 300 s resting period, 180 s of ischaemia and
400 s of reactive hyperaemia. Four axial slices (thickness
5 mm, gap 2.5 mm) were positioned in the upper calf. With
each excitation, four echo images with increasing effective
echo times were acquired. Inflow (initial signal intensity, I0)
and oxygenation (susceptibility, T2*) effects were sepa-
rated by a pixel-by-pixel least-square fit of a monoexponen-
tial decay to the signal intensities at the four different echo
times (TE14 of 9.3, 20.1, 31.0 and 41.5 ms) according to
S(I0, T2*) = I0 exp(TE14/T2*). T2* maps were computed,
supplemented with T1-reference images and ROIs placed
in the soleus, gastrocnemius and peroneus, excluding
pixels of bones and vessels (Fig. 1).
(i) Absolute baseline T2* values were comparable be-
tween the two individuals (patient 21.6 ms, control
21.1 ms).
(ii) Absolute and relative minimum ischaemic T2*
values (T2*min) were substantially lower in the GPA
patient (15.3 ms, 29.4%) than in the control
(19.7 ms, 9.5%).
(iii) Relative T2* decline after cuff compression
[ischaemic declining slope (IDS)] was significantly
steeper in the GPA patient, when compared with
the healthy volunteer (4.1%/ms vs 1.0%/ms).
(iv) Absolute and relative T2* peak values during react-
ive hyperaemia (T2*max) were strongly reduced in
the patient (23.6 ms, +7.0% vs 25.0 ms, +18.4%).
(v) Time to peak value (TTP), reflecting the time from
cuff deflation to T2*max, was similar between the
two subjects (32 s vs 34 s).
(vi) T2* end value (EV, reflecting medium T2* during the
last 10 s of measurement) was higher in the GPA
patient compared with the control.
These findings strongly suggest major perturbations of
skeletal muscle microcirculation in this GPA patient,
revealed by skeletal muscle BOLD MRI. The lower
T2*min value in the patient might be explained by
increased oxygen consumption as control and patient
showed comparable baseline absolute T2* values, and
the IDS absolute value was substantially higher in the pa-
tient. This might be a compensatory mechanism for
chronic hypoxic conditions in patients with GPA. T2*max
decrease could be explained by reduced blood flow in
skeletal muscle microvessels, owing to small vessel vas-
culitis. The underlying mechanisms of the detected BOLD
alterations have to be interpreted with care owing to other
T2* influencing factors such as blood volume, haemato-
crit, functional vascular status and metabolic changes [5,
7]. Owing to the lack of reference methods for the meas-
urement of perfusion or oxygenation, our findings remain
mostly descriptive. However, the measured BOLD re-
sponse in GPA is different from previous results in patients
with atherosclerosis that showed diminished ischaemic
T2* decline and a prolonged TTP [5, 10]. This may indicate
that other mechanisms besides accelerated atheroscler-
osis play an important role in the pathogenesis of skeletal
muscle microcirculation alterations in GPA. Of course,
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further studies with larger patient collectives are war-
ranted to elucidate the underlying mechanisms of the
described BOLD signal alterations in GPA.
Rheumatology key message
. Alterations of skeletal muscle microcirculation in
GPA can be revealed by BOLD MRI.
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Vasculitis following HPV immunization
Sir, we report two cases of vasculitis following HPV
immunization, which has not previously been described.
Case 1, a 15-year-old girl, presented with three small pur-
puric lesions on the lower left leg 3 days after the second
dose of the HPV vaccine. These progressed over the next
2 weeks to a florid purpuric rash affecting the lower limbs,
buttocks and extensor surfaces of both elbows. She was
afebrile, with no abdominal pain or arthritis; blood pres-
sure was normal. Urinalysis showed +++ of blood but no
protein or nitrates.
A diagnosis of probable HenochScho¨nlein purpura
(HSP) was made. Two weeks later she re-presented with
extensive generalized vasculitic rash, soft tissue swellings
of both ankles and forearms, arthralgia, lethargy and epi-
staxis. Laboratory tests were normal (CRP <5 mg/l, ESR
25 mm/h). Full autoantibody screen was negative; com-
plement (C3, C4) and serum immunoglobulins were
normal. Skin biopsy showed a mild perivascular lympho-
cytic inflammatory cell infiltrate and occasional eosinophil
interstitial infiltrate. The swellings and cutaneous vasculitis
initially improved with oral prednisolone and antibiotics
but deteriorated dramatically as CSs were discontinued.
Ten weeks after the initial presentation, the vasculitic rash
was re-biopsied, revealing a leukocytoclastic vasculitis
(LV); immunofluorescence was negative for IgA depos-
ition. Treatment with prednisolone (0.5 mg/kg/day) and
colchicine (1500 mg/day) was started. Azathioprine was
subsequently added as an additional steroid-sparing
agent, which led to resolution of the vasculitis and suc-
cessful steroid taper.
Case 2 was diagnosed with HSP at the age of 13 years
with typical cutaneous vasculitis, abdominal pain, arthral-
gia and microscopic haematuria. Laboratory tests includ-
ing renal function, inflammatory parameters and full
autoimmune workup were normal. IgA was elevated at
3.54 g/l (0.82.8). Infectious workup was negative. Over
the next 2 years there was gradual resolution with recur-
rent vasculitic skin rash lasting for a few days mainly after
intercurrent infections. Aged 15 years, with the vasculitis
in remission, the first dose of the HPV bivalent vaccine
was given. Three days later she had a severe flare of cu-
taneous vasculitis. Laboratory tests were as previously
documented. Skin biopsy showed endothelial cell hyper-
plasia and neutrophil infiltration into the vessels within the
dermis, compatible with acute cutaneous vasculitis.
Immunofluorescence for IgA, IgG, IgM, C1q, C3 and
fibrin was negative and consistent with cutaneous LV [1].
To the best of our knowledge, these are the first
reports of vasculitis associated with the HPV vaccine.
Both cases presented with a small-size vessel vasculitis
predominantly affecting the skin soon after HPV vaccin-
ation, the first being a de novo isolated cutaneous LV and
the second a vasculitis recurrence. Immunization with
HPV vaccine has the potential to decrease the global
morbidity and mortality of HPV-related disease, including
cervical cancer, and thus represents a major break-
through in medicine [2]. As HPV 16 and 18 are involved
in the pathogenesis of 7075% of all cases of invasive
cervical cancer, vaccination in this context offers an
effective means of primary cancer prevention [3] and is
only the second vaccine that has been licensed with this
indication [4].
Overall the balance between the risks and benefits of
the HPV vaccine is overwhelmingly positive. A recently
published pooled analysis of 11 clinical trials showed no
significant differences between the vaccine and the
control group regarding severe side effects or the devel-
opment of chronic illnesses including autoimmune dis-
eases [5].
LV is the most frequent form of vasculitis affecting the
skin, involving small vessels but particularly post-capillary
venules. In many cases, LV is caused by large immune
complexes deposited at the vessel wall, which can be
either IgA (as in HSP) or contain IgM or IgG. LV can also
be secondary to ANCA-associated vasculitis and can
occur without immune complex deposition [6]. The failure
to demonstrate IgA deposits by immunofluorescence on
skin biopsy makes these cases better classified as hyper-
sensitivity cutaneous LV despite the initial presumptive
clinical diagnosis of HSP [7].
Several infectious agents and drugs have been incon-
clusively identified as possible infective triggers of
hypersensitivity LV. In our reported cases, there was
no history of preceding infection, and the strong tem-
poral relationship between the administration of the bi-
valent HPV vaccine and the development of vasculitis
was notable.
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